Pages that link to "Q36773984"
Jump to navigation
Jump to search
The following pages link to Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease (Q36773984):
Displaying 50 items.
- Brain and Retinal Pericytes: Origin, Function and Role (Q26766504) (← links)
- Cerebrovascular disease in ageing and Alzheimer's disease (Q26771852) (← links)
- Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions (Q26781557) (← links)
- The pericyte: a forgotten cell type with important implications for Alzheimer's disease? (Q26852369) (← links)
- Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms (Q27001177) (← links)
- Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease (Q27008456) (← links)
- Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease (Q27011505) (← links)
- The restorative role of annexin A1 at the blood-brain barrier. (Q27687514) (← links)
- Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease (Q28087176) (← links)
- Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders (Q29048615) (← links)
- Endothelial cells and human cerebral small vessel disease. (Q30880425) (← links)
- Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease (Q33555571) (← links)
- Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling (Q33602690) (← links)
- Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation. (Q34227162) (← links)
- Redistribution of PDGFRβ cells and NG2DsRed pericytes at the cerebrovasculature after status epilepticus (Q34266638) (← links)
- Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people. (Q34406773) (← links)
- Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury (Q34614529) (← links)
- Hypoxia/Aglycemia-induced endothelial barrier dysfunction and tight junction protein downregulation can be ameliorated by citicoline (Q35072864) (← links)
- Blood-brain barrier breakdown in the aging human hippocampus (Q35151019) (← links)
- Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy (Q35158609) (← links)
- Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological study (Q35305259) (← links)
- Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system (Q35561041) (← links)
- Striatal blood-brain barrier permeability in Parkinson's disease (Q35572836) (← links)
- Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (Q35757111) (← links)
- APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction. (Q35825824) (← links)
- Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice. (Q35995420) (← links)
- Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model (Q36137343) (← links)
- Epithelial cells supply Sonic Hedgehog to the perinatal dentate gyrus via transport by platelets (Q36145982) (← links)
- Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes (Q36244872) (← links)
- Establishment and Dysfunction of the Blood-Brain Barrier (Q36306827) (← links)
- The neuropathology and cerebrovascular mechanisms of dementia (Q36593201) (← links)
- Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. (Q36593210) (← links)
- Neurovascular and Immuno-Imaging: From Mechanisms to Therapies. Proceedings of the Inaugural Symposium (Q36602139) (← links)
- Dysfunction of brain pericytes in chronic neuroinflammation. (Q36765848) (← links)
- Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease (Q36767796) (← links)
- Heterogeneity of the blood-brain barrier (Q36812384) (← links)
- Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia (Q36828651) (← links)
- Meox2 haploinsufficiency increases neuronal cell loss in a mouse model of Alzheimer's disease (Q36929768) (← links)
- Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. (Q37216153) (← links)
- Analysis of the brain mural cell transcriptome (Q37325417) (← links)
- Notch3 establishes brain vascular integrity by regulating pericyte number. (Q37429344) (← links)
- The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease (Q37485028) (← links)
- Pericyte loss influences Alzheimer-like neurodegeneration in mice. (Q37623577) (← links)
- Blood-brain barrier structure and function and the challenges for CNS drug delivery (Q38100970) (← links)
- 'Sealing off the CNS': cellular and molecular regulation of blood-brain barriergenesis (Q38122509) (← links)
- Pericytes: brain-immune interface modulators (Q38181071) (← links)
- The role of pericytes in neurovascular unit remodeling in brain disorders (Q38205364) (← links)
- Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease (Q38542827) (← links)
- Neuropathology of White Matter Lesions, Blood-Brain Barrier Dysfunction, and Dementia. (Q38601654) (← links)
- Targeting cerebrovascular impairments in Huntington's disease: a novel treatment perspective. (Q38620375) (← links)